Showing results (961-970 of 6,608) with videos related to
Sort By:
Pageof 661
Hepatology (Baltimore, Md.)|August 26, 1999
Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial GroupR N Chien, Y F Liaw, M AtkinsLeukemia Research|January 1, 1990
T cells and CD45R expression in B-chronic lymphocytic leukemiaP G Briggs, N Kraft, R C AtkinsMarine Pollution Bulletin|October 20, 2007
An application of contingent valuation and decision tree analysis to water quality improvementsJonathan P Atkins, Daryl Burdon, James H AllenJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1991
Validation requirements for ambulatory blood pressure measuring systemsE O'Brien, F Mee, N Atkins, et al.Journal of Bacteriology|February 11, 1999
Functional determinants of the Escherichia coli fis promoter: roles of -35, -10, and transcription initiation regions in the response to stringent control and growth phase-dependent regulationK A Walker, C L Atkins, R OsunaPathology|October 1, 1982
The immunohistochemical demonstration of major histocompatibility antigens in the human kidney using monoclonal antibodiesW W Hancock, N Kraft, R C AtkinsInternational Journal of Peptide and Protein Research|October 1, 1994
Conformational stability of the endothelin/sarafotoxin family of peptidesA R Atkins, G B Ralston, R SmithBiomedical Instrumentation & Technology|September 1, 1992
The quest for better validation: a critical comparison of the AAMI and BHS validation protocols for ambulatory blood pressure measurement systemsE O'Brien, F Mee, N Atkins, et al.Blood Pressure|December 1, 1993
Antihypertensive therapy and circadian blood pressure profiles: a retrospective analysis utilising cumulative sumsA Stanton, N Atkins, E O'Brien, et al.Pageof 661